Mohammad Mohammadianpanah

11PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 27, 2026
Southern Iran tertiary-center validation of 5-year disease free survival and overall survival rates in tongue squamous cell carcinoma: a confirmatory retrospective 10-years cohort study.

|Apr 02, 2026
Preventive effects of dexamethasone oral solution on radiation-induced mucositis in patients with head and neck cancer: a randomized, triple-blind, parallel-group trial.

Niloofar Ahmadlo, Nooshin Dindar, Mohammad Mohammadianpanah

|Aug 29, 2025
Guardians of Sensation: Evaluating Metformin's Power Against Chemotherapy-Induced Neuropathy.

Hamid Nasrolahi, Ahmad Mosalaei, Susan Andalibi

|Dec 06, 2024
The predictive and prognostic value of tumor-stromal ratio and tumor budding in the recurrence and outcome of patients with oral tongue squamous cell carcinoma.

Zahra Mansouri, Mehdi Mohammadianpanah, Mahsa Kohandel-Shirazi

|Sep 14, 2024
Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group.

Nam P Nguyen, Brandi R Page, Huan Giap

|Oct 28, 2023
Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.

Nam P Nguyen, Juliette Thariat, Olena Gorobets

Pageof 2

Frequent Collaborators

5 joint publications

Shapour Omidvari

4 joint publications

Hamid Nasrollahi

3 joint publications

Ahmad Mosalaei

3 joint publications

Niloofar Ahmadloo